nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamsulosin—CYP2D6—breast cancer	0.181	0.538	CbGaD
Tamsulosin—CYP3A4—breast cancer	0.155	0.462	CbGaD
Tamsulosin—CYP3A4—Exemestane—breast cancer	0.0344	0.103	CbGbCtD
Tamsulosin—CYP2D6—Idarubicin—breast cancer	0.0311	0.093	CbGbCtD
Tamsulosin—CYP3A4—Letrozole—breast cancer	0.0293	0.0876	CbGbCtD
Tamsulosin—CYP3A4—Anastrozole—breast cancer	0.0261	0.0781	CbGbCtD
Tamsulosin—CYP3A4—Toremifene—breast cancer	0.0239	0.0714	CbGbCtD
Tamsulosin—CYP3A4—Fulvestrant—breast cancer	0.0222	0.0664	CbGbCtD
Tamsulosin—CYP3A4—Thiotepa—breast cancer	0.0198	0.0592	CbGbCtD
Tamsulosin—CYP3A4—Ixabepilone—breast cancer	0.0181	0.0541	CbGbCtD
Tamsulosin—CYP3A4—Lapatinib—breast cancer	0.0174	0.0521	CbGbCtD
Tamsulosin—CYP2D6—Vinorelbine—breast cancer	0.0152	0.0454	CbGbCtD
Tamsulosin—CYP2D6—Tamoxifen—breast cancer	0.0137	0.041	CbGbCtD
Tamsulosin—CYP3A4—Raloxifene—breast cancer	0.0132	0.0395	CbGbCtD
Tamsulosin—CYP3A4—Vinorelbine—breast cancer	0.00965	0.0289	CbGbCtD
Tamsulosin—CYP2D6—Vinblastine—breast cancer	0.00935	0.028	CbGbCtD
Tamsulosin—CYP3A4—Tamoxifen—breast cancer	0.00871	0.0261	CbGbCtD
Tamsulosin—CYP3A4—Mitoxantrone—breast cancer	0.0085	0.0254	CbGbCtD
Tamsulosin—CYP3A4—Paclitaxel—breast cancer	0.00678	0.0203	CbGbCtD
Tamsulosin—CYP3A4—Irinotecan—breast cancer	0.00669	0.02	CbGbCtD
Tamsulosin—CYP3A4—Vinblastine—breast cancer	0.00595	0.0178	CbGbCtD
Tamsulosin—CYP2D6—Doxorubicin—breast cancer	0.00575	0.0172	CbGbCtD
Tamsulosin—CYP3A4—Docetaxel—breast cancer	0.0049	0.0147	CbGbCtD
Tamsulosin—CYP3A4—Doxorubicin—breast cancer	0.00365	0.0109	CbGbCtD
Tamsulosin—Carvedilol—HIF1A—breast cancer	0.00131	0.252	CrCbGaD
Tamsulosin—Bumetanide—CA9—breast cancer	0.000888	0.17	CrCbGaD
Tamsulosin—Silodosin—CYP3A4—breast cancer	0.000664	0.127	CrCbGaD
Tamsulosin—Silodosin—ABCB1—breast cancer	0.000553	0.106	CrCbGaD
Tamsulosin—Carvedilol—VEGFA—breast cancer	0.000529	0.101	CrCbGaD
Tamsulosin—Carvedilol—PTGS1—breast cancer	0.000279	0.0535	CrCbGaD
Tamsulosin—Carvedilol—CYP1A1—breast cancer	0.000255	0.0489	CrCbGaD
Tamsulosin—Bumetanide—PTGS2—breast cancer	0.00025	0.048	CrCbGaD
Tamsulosin—Carvedilol—CYP2D6—breast cancer	0.00019	0.0364	CrCbGaD
Tamsulosin—Carvedilol—CYP3A4—breast cancer	0.000163	0.0312	CrCbGaD
Tamsulosin—Carvedilol—ABCB1—breast cancer	0.000136	0.026	CrCbGaD
Tamsulosin—Cardiac disorder—Methotrexate—breast cancer	7.47e-05	0.000309	CcSEcCtD
Tamsulosin—Skin disorder—Capecitabine—breast cancer	7.46e-05	0.000309	CcSEcCtD
Tamsulosin—Sweating—Doxorubicin—breast cancer	7.45e-05	0.000308	CcSEcCtD
Tamsulosin—Urticaria—Paclitaxel—breast cancer	7.44e-05	0.000308	CcSEcCtD
Tamsulosin—Hyperhidrosis—Capecitabine—breast cancer	7.43e-05	0.000307	CcSEcCtD
Tamsulosin—Oedema peripheral—Epirubicin—breast cancer	7.42e-05	0.000307	CcSEcCtD
Tamsulosin—Hypotension—Docetaxel—breast cancer	7.42e-05	0.000307	CcSEcCtD
Tamsulosin—Connective tissue disorder—Epirubicin—breast cancer	7.4e-05	0.000306	CcSEcCtD
Tamsulosin—Body temperature increased—Paclitaxel—breast cancer	7.4e-05	0.000306	CcSEcCtD
Tamsulosin—Abdominal pain—Paclitaxel—breast cancer	7.4e-05	0.000306	CcSEcCtD
Tamsulosin—Epistaxis—Doxorubicin—breast cancer	7.33e-05	0.000303	CcSEcCtD
Tamsulosin—Angiopathy—Methotrexate—breast cancer	7.31e-05	0.000302	CcSEcCtD
Tamsulosin—Vomiting—Mitoxantrone—breast cancer	7.3e-05	0.000302	CcSEcCtD
Tamsulosin—Vomiting—Irinotecan—breast cancer	7.3e-05	0.000302	CcSEcCtD
Tamsulosin—Sinusitis—Doxorubicin—breast cancer	7.29e-05	0.000301	CcSEcCtD
Tamsulosin—Dizziness—Fluorouracil—breast cancer	7.27e-05	0.000301	CcSEcCtD
Tamsulosin—Visual impairment—Epirubicin—breast cancer	7.26e-05	0.0003	CcSEcCtD
Tamsulosin—Mediastinal disorder—Methotrexate—breast cancer	7.26e-05	0.0003	CcSEcCtD
Tamsulosin—Rash—Irinotecan—breast cancer	7.24e-05	0.000299	CcSEcCtD
Tamsulosin—Rash—Mitoxantrone—breast cancer	7.24e-05	0.000299	CcSEcCtD
Tamsulosin—Dermatitis—Irinotecan—breast cancer	7.23e-05	0.000299	CcSEcCtD
Tamsulosin—Dermatitis—Mitoxantrone—breast cancer	7.23e-05	0.000299	CcSEcCtD
Tamsulosin—Musculoskeletal discomfort—Docetaxel—breast cancer	7.23e-05	0.000299	CcSEcCtD
Tamsulosin—Chills—Methotrexate—breast cancer	7.22e-05	0.000299	CcSEcCtD
Tamsulosin—Headache—Mitoxantrone—breast cancer	7.19e-05	0.000298	CcSEcCtD
Tamsulosin—Headache—Irinotecan—breast cancer	7.19e-05	0.000298	CcSEcCtD
Tamsulosin—Hypotension—Capecitabine—breast cancer	7.18e-05	0.000297	CcSEcCtD
Tamsulosin—Insomnia—Docetaxel—breast cancer	7.18e-05	0.000297	CcSEcCtD
Tamsulosin—Paraesthesia—Docetaxel—breast cancer	7.13e-05	0.000295	CcSEcCtD
Tamsulosin—Erythema multiforme—Epirubicin—breast cancer	7.12e-05	0.000295	CcSEcCtD
Tamsulosin—Vomiting—Gemcitabine—breast cancer	7.11e-05	0.000294	CcSEcCtD
Tamsulosin—Dyspnoea—Docetaxel—breast cancer	7.08e-05	0.000293	CcSEcCtD
Tamsulosin—Somnolence—Docetaxel—breast cancer	7.06e-05	0.000292	CcSEcCtD
Tamsulosin—Rash—Gemcitabine—breast cancer	7.05e-05	0.000292	CcSEcCtD
Tamsulosin—Dermatitis—Gemcitabine—breast cancer	7.05e-05	0.000291	CcSEcCtD
Tamsulosin—Malnutrition—Methotrexate—breast cancer	7.01e-05	0.00029	CcSEcCtD
Tamsulosin—Headache—Gemcitabine—breast cancer	7.01e-05	0.00029	CcSEcCtD
Tamsulosin—Musculoskeletal discomfort—Capecitabine—breast cancer	7e-05	0.00029	CcSEcCtD
Tamsulosin—Cardiac disorder—Epirubicin—breast cancer	6.99e-05	0.000289	CcSEcCtD
Tamsulosin—Vomiting—Fluorouracil—breast cancer	6.99e-05	0.000289	CcSEcCtD
Tamsulosin—Rhinitis—Doxorubicin—breast cancer	6.99e-05	0.000289	CcSEcCtD
Tamsulosin—Dyspepsia—Docetaxel—breast cancer	6.99e-05	0.000289	CcSEcCtD
Tamsulosin—Insomnia—Capecitabine—breast cancer	6.95e-05	0.000288	CcSEcCtD
Tamsulosin—Rash—Fluorouracil—breast cancer	6.93e-05	0.000287	CcSEcCtD
Tamsulosin—Dermatitis—Fluorouracil—breast cancer	6.93e-05	0.000287	CcSEcCtD
Tamsulosin—Pharyngitis—Doxorubicin—breast cancer	6.92e-05	0.000286	CcSEcCtD
Tamsulosin—Paraesthesia—Capecitabine—breast cancer	6.9e-05	0.000285	CcSEcCtD
Tamsulosin—Hypersensitivity—Paclitaxel—breast cancer	6.9e-05	0.000285	CcSEcCtD
Tamsulosin—Headache—Fluorouracil—breast cancer	6.89e-05	0.000285	CcSEcCtD
Tamsulosin—Oedema peripheral—Doxorubicin—breast cancer	6.87e-05	0.000284	CcSEcCtD
Tamsulosin—Gastrointestinal disorder—Docetaxel—breast cancer	6.85e-05	0.000283	CcSEcCtD
Tamsulosin—Connective tissue disorder—Doxorubicin—breast cancer	6.85e-05	0.000283	CcSEcCtD
Tamsulosin—Dyspnoea—Capecitabine—breast cancer	6.85e-05	0.000283	CcSEcCtD
Tamsulosin—Fatigue—Docetaxel—breast cancer	6.84e-05	0.000283	CcSEcCtD
Tamsulosin—Angiopathy—Epirubicin—breast cancer	6.84e-05	0.000283	CcSEcCtD
Tamsulosin—Nausea—Irinotecan—breast cancer	6.82e-05	0.000282	CcSEcCtD
Tamsulosin—Nausea—Mitoxantrone—breast cancer	6.82e-05	0.000282	CcSEcCtD
Tamsulosin—Mediastinal disorder—Epirubicin—breast cancer	6.79e-05	0.000281	CcSEcCtD
Tamsulosin—Pain—Docetaxel—breast cancer	6.79e-05	0.000281	CcSEcCtD
Tamsulosin—Constipation—Docetaxel—breast cancer	6.79e-05	0.000281	CcSEcCtD
Tamsulosin—Back pain—Methotrexate—breast cancer	6.78e-05	0.00028	CcSEcCtD
Tamsulosin—Dyspepsia—Capecitabine—breast cancer	6.76e-05	0.00028	CcSEcCtD
Tamsulosin—Chills—Epirubicin—breast cancer	6.76e-05	0.00028	CcSEcCtD
Tamsulosin—Arrhythmia—Epirubicin—breast cancer	6.73e-05	0.000278	CcSEcCtD
Tamsulosin—Visual impairment—Doxorubicin—breast cancer	6.72e-05	0.000278	CcSEcCtD
Tamsulosin—Asthenia—Paclitaxel—breast cancer	6.72e-05	0.000278	CcSEcCtD
Tamsulosin—Nausea—Gemcitabine—breast cancer	6.64e-05	0.000275	CcSEcCtD
Tamsulosin—Gastrointestinal disorder—Capecitabine—breast cancer	6.63e-05	0.000274	CcSEcCtD
Tamsulosin—Fatigue—Capecitabine—breast cancer	6.63e-05	0.000274	CcSEcCtD
Tamsulosin—Pruritus—Paclitaxel—breast cancer	6.62e-05	0.000274	CcSEcCtD
Tamsulosin—Vision blurred—Methotrexate—breast cancer	6.61e-05	0.000273	CcSEcCtD
Tamsulosin—Erythema multiforme—Doxorubicin—breast cancer	6.59e-05	0.000273	CcSEcCtD
Tamsulosin—Constipation—Capecitabine—breast cancer	6.57e-05	0.000272	CcSEcCtD
Tamsulosin—Pain—Capecitabine—breast cancer	6.57e-05	0.000272	CcSEcCtD
Tamsulosin—Malnutrition—Epirubicin—breast cancer	6.56e-05	0.000271	CcSEcCtD
Tamsulosin—Feeling abnormal—Docetaxel—breast cancer	6.54e-05	0.000271	CcSEcCtD
Tamsulosin—Nausea—Fluorouracil—breast cancer	6.53e-05	0.00027	CcSEcCtD
Tamsulosin—Ill-defined disorder—Methotrexate—breast cancer	6.5e-05	0.000269	CcSEcCtD
Tamsulosin—Gastrointestinal pain—Docetaxel—breast cancer	6.49e-05	0.000268	CcSEcCtD
Tamsulosin—Cardiac disorder—Doxorubicin—breast cancer	6.47e-05	0.000268	CcSEcCtD
Tamsulosin—Diarrhoea—Paclitaxel—breast cancer	6.41e-05	0.000265	CcSEcCtD
Tamsulosin—Back pain—Epirubicin—breast cancer	6.34e-05	0.000262	CcSEcCtD
Tamsulosin—Feeling abnormal—Capecitabine—breast cancer	6.33e-05	0.000262	CcSEcCtD
Tamsulosin—Angiopathy—Doxorubicin—breast cancer	6.33e-05	0.000262	CcSEcCtD
Tamsulosin—Malaise—Methotrexate—breast cancer	6.32e-05	0.000261	CcSEcCtD
Tamsulosin—Vertigo—Methotrexate—breast cancer	6.3e-05	0.000261	CcSEcCtD
Tamsulosin—Gastrointestinal pain—Capecitabine—breast cancer	6.28e-05	0.00026	CcSEcCtD
Tamsulosin—Mediastinal disorder—Doxorubicin—breast cancer	6.28e-05	0.00026	CcSEcCtD
Tamsulosin—Abdominal pain—Docetaxel—breast cancer	6.27e-05	0.00026	CcSEcCtD
Tamsulosin—Body temperature increased—Docetaxel—breast cancer	6.27e-05	0.00026	CcSEcCtD
Tamsulosin—Chills—Doxorubicin—breast cancer	6.26e-05	0.000259	CcSEcCtD
Tamsulosin—Arrhythmia—Doxorubicin—breast cancer	6.23e-05	0.000258	CcSEcCtD
Tamsulosin—Dizziness—Paclitaxel—breast cancer	6.19e-05	0.000256	CcSEcCtD
Tamsulosin—Vision blurred—Epirubicin—breast cancer	6.18e-05	0.000256	CcSEcCtD
Tamsulosin—Cough—Methotrexate—breast cancer	6.12e-05	0.000253	CcSEcCtD
Tamsulosin—Urticaria—Capecitabine—breast cancer	6.1e-05	0.000253	CcSEcCtD
Tamsulosin—Ill-defined disorder—Epirubicin—breast cancer	6.09e-05	0.000252	CcSEcCtD
Tamsulosin—Abdominal pain—Capecitabine—breast cancer	6.07e-05	0.000251	CcSEcCtD
Tamsulosin—Body temperature increased—Capecitabine—breast cancer	6.07e-05	0.000251	CcSEcCtD
Tamsulosin—Malnutrition—Doxorubicin—breast cancer	6.07e-05	0.000251	CcSEcCtD
Tamsulosin—Myalgia—Methotrexate—breast cancer	5.97e-05	0.000247	CcSEcCtD
Tamsulosin—Arthralgia—Methotrexate—breast cancer	5.97e-05	0.000247	CcSEcCtD
Tamsulosin—Chest pain—Methotrexate—breast cancer	5.97e-05	0.000247	CcSEcCtD
Tamsulosin—Vomiting—Paclitaxel—breast cancer	5.95e-05	0.000246	CcSEcCtD
Tamsulosin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	5.93e-05	0.000245	CcSEcCtD
Tamsulosin—Malaise—Epirubicin—breast cancer	5.92e-05	0.000245	CcSEcCtD
Tamsulosin—Rash—Paclitaxel—breast cancer	5.9e-05	0.000244	CcSEcCtD
Tamsulosin—Dermatitis—Paclitaxel—breast cancer	5.9e-05	0.000244	CcSEcCtD
Tamsulosin—Discomfort—Methotrexate—breast cancer	5.9e-05	0.000244	CcSEcCtD
Tamsulosin—Vertigo—Epirubicin—breast cancer	5.89e-05	0.000244	CcSEcCtD
Tamsulosin—Syncope—Epirubicin—breast cancer	5.88e-05	0.000243	CcSEcCtD
Tamsulosin—Back pain—Doxorubicin—breast cancer	5.87e-05	0.000243	CcSEcCtD
Tamsulosin—Headache—Paclitaxel—breast cancer	5.87e-05	0.000243	CcSEcCtD
Tamsulosin—Hypersensitivity—Docetaxel—breast cancer	5.85e-05	0.000242	CcSEcCtD
Tamsulosin—Palpitations—Epirubicin—breast cancer	5.8e-05	0.00024	CcSEcCtD
Tamsulosin—Loss of consciousness—Epirubicin—breast cancer	5.77e-05	0.000238	CcSEcCtD
Tamsulosin—Cough—Epirubicin—breast cancer	5.72e-05	0.000237	CcSEcCtD
Tamsulosin—Vision blurred—Doxorubicin—breast cancer	5.72e-05	0.000237	CcSEcCtD
Tamsulosin—Asthenia—Docetaxel—breast cancer	5.69e-05	0.000236	CcSEcCtD
Tamsulosin—Infection—Methotrexate—breast cancer	5.68e-05	0.000235	CcSEcCtD
Tamsulosin—Hypertension—Epirubicin—breast cancer	5.66e-05	0.000234	CcSEcCtD
Tamsulosin—Hypersensitivity—Capecitabine—breast cancer	5.66e-05	0.000234	CcSEcCtD
Tamsulosin—Ill-defined disorder—Doxorubicin—breast cancer	5.63e-05	0.000233	CcSEcCtD
Tamsulosin—Pruritus—Docetaxel—breast cancer	5.62e-05	0.000232	CcSEcCtD
Tamsulosin—Nervous system disorder—Methotrexate—breast cancer	5.61e-05	0.000232	CcSEcCtD
Tamsulosin—Arthralgia—Epirubicin—breast cancer	5.58e-05	0.000231	CcSEcCtD
Tamsulosin—Chest pain—Epirubicin—breast cancer	5.58e-05	0.000231	CcSEcCtD
Tamsulosin—Myalgia—Epirubicin—breast cancer	5.58e-05	0.000231	CcSEcCtD
Tamsulosin—Nausea—Paclitaxel—breast cancer	5.56e-05	0.00023	CcSEcCtD
Tamsulosin—Skin disorder—Methotrexate—breast cancer	5.56e-05	0.00023	CcSEcCtD
Tamsulosin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	5.55e-05	0.000229	CcSEcCtD
Tamsulosin—Hyperhidrosis—Methotrexate—breast cancer	5.53e-05	0.000229	CcSEcCtD
Tamsulosin—Discomfort—Epirubicin—breast cancer	5.52e-05	0.000228	CcSEcCtD
Tamsulosin—Asthenia—Capecitabine—breast cancer	5.51e-05	0.000228	CcSEcCtD
Tamsulosin—Malaise—Doxorubicin—breast cancer	5.47e-05	0.000226	CcSEcCtD
Tamsulosin—Vertigo—Doxorubicin—breast cancer	5.45e-05	0.000226	CcSEcCtD
Tamsulosin—Syncope—Doxorubicin—breast cancer	5.44e-05	0.000225	CcSEcCtD
Tamsulosin—Pruritus—Capecitabine—breast cancer	5.44e-05	0.000225	CcSEcCtD
Tamsulosin—Diarrhoea—Docetaxel—breast cancer	5.43e-05	0.000225	CcSEcCtD
Tamsulosin—Palpitations—Doxorubicin—breast cancer	5.36e-05	0.000222	CcSEcCtD
Tamsulosin—Hypotension—Methotrexate—breast cancer	5.35e-05	0.000221	CcSEcCtD
Tamsulosin—Loss of consciousness—Doxorubicin—breast cancer	5.33e-05	0.000221	CcSEcCtD
Tamsulosin—Infection—Epirubicin—breast cancer	5.32e-05	0.00022	CcSEcCtD
Tamsulosin—Cough—Doxorubicin—breast cancer	5.3e-05	0.000219	CcSEcCtD
Tamsulosin—Shock—Epirubicin—breast cancer	5.27e-05	0.000218	CcSEcCtD
Tamsulosin—Diarrhoea—Capecitabine—breast cancer	5.26e-05	0.000218	CcSEcCtD
Tamsulosin—Nervous system disorder—Epirubicin—breast cancer	5.25e-05	0.000217	CcSEcCtD
Tamsulosin—Dizziness—Docetaxel—breast cancer	5.25e-05	0.000217	CcSEcCtD
Tamsulosin—Hypertension—Doxorubicin—breast cancer	5.24e-05	0.000217	CcSEcCtD
Tamsulosin—Tachycardia—Epirubicin—breast cancer	5.22e-05	0.000216	CcSEcCtD
Tamsulosin—Musculoskeletal discomfort—Methotrexate—breast cancer	5.21e-05	0.000216	CcSEcCtD
Tamsulosin—Skin disorder—Epirubicin—breast cancer	5.2e-05	0.000215	CcSEcCtD
Tamsulosin—Hyperhidrosis—Epirubicin—breast cancer	5.18e-05	0.000214	CcSEcCtD
Tamsulosin—Insomnia—Methotrexate—breast cancer	5.17e-05	0.000214	CcSEcCtD
Tamsulosin—Myalgia—Doxorubicin—breast cancer	5.17e-05	0.000214	CcSEcCtD
Tamsulosin—Chest pain—Doxorubicin—breast cancer	5.17e-05	0.000214	CcSEcCtD
Tamsulosin—Arthralgia—Doxorubicin—breast cancer	5.17e-05	0.000214	CcSEcCtD
Tamsulosin—Paraesthesia—Methotrexate—breast cancer	5.14e-05	0.000212	CcSEcCtD
Tamsulosin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	5.13e-05	0.000212	CcSEcCtD
Tamsulosin—Discomfort—Doxorubicin—breast cancer	5.11e-05	0.000211	CcSEcCtD
Tamsulosin—Dyspnoea—Methotrexate—breast cancer	5.1e-05	0.000211	CcSEcCtD
Tamsulosin—Somnolence—Methotrexate—breast cancer	5.09e-05	0.00021	CcSEcCtD
Tamsulosin—Dizziness—Capecitabine—breast cancer	5.08e-05	0.00021	CcSEcCtD
Tamsulosin—Vomiting—Docetaxel—breast cancer	5.05e-05	0.000209	CcSEcCtD
Tamsulosin—Dyspepsia—Methotrexate—breast cancer	5.04e-05	0.000208	CcSEcCtD
Tamsulosin—Rash—Docetaxel—breast cancer	5e-05	0.000207	CcSEcCtD
Tamsulosin—Hypotension—Epirubicin—breast cancer	5e-05	0.000207	CcSEcCtD
Tamsulosin—Dermatitis—Docetaxel—breast cancer	5e-05	0.000207	CcSEcCtD
Tamsulosin—Headache—Docetaxel—breast cancer	4.97e-05	0.000206	CcSEcCtD
Tamsulosin—Gastrointestinal disorder—Methotrexate—breast cancer	4.94e-05	0.000204	CcSEcCtD
Tamsulosin—Fatigue—Methotrexate—breast cancer	4.93e-05	0.000204	CcSEcCtD
Tamsulosin—Infection—Doxorubicin—breast cancer	4.92e-05	0.000204	CcSEcCtD
Tamsulosin—Pain—Methotrexate—breast cancer	4.89e-05	0.000202	CcSEcCtD
Tamsulosin—Vomiting—Capecitabine—breast cancer	4.89e-05	0.000202	CcSEcCtD
Tamsulosin—Musculoskeletal discomfort—Epirubicin—breast cancer	4.88e-05	0.000202	CcSEcCtD
Tamsulosin—Shock—Doxorubicin—breast cancer	4.87e-05	0.000202	CcSEcCtD
Tamsulosin—Nervous system disorder—Doxorubicin—breast cancer	4.86e-05	0.000201	CcSEcCtD
Tamsulosin—Rash—Capecitabine—breast cancer	4.85e-05	0.0002	CcSEcCtD
Tamsulosin—Insomnia—Epirubicin—breast cancer	4.84e-05	0.0002	CcSEcCtD
Tamsulosin—Dermatitis—Capecitabine—breast cancer	4.84e-05	0.0002	CcSEcCtD
Tamsulosin—Tachycardia—Doxorubicin—breast cancer	4.83e-05	0.0002	CcSEcCtD
Tamsulosin—Headache—Capecitabine—breast cancer	4.81e-05	0.000199	CcSEcCtD
Tamsulosin—Skin disorder—Doxorubicin—breast cancer	4.81e-05	0.000199	CcSEcCtD
Tamsulosin—Paraesthesia—Epirubicin—breast cancer	4.81e-05	0.000199	CcSEcCtD
Tamsulosin—Hyperhidrosis—Doxorubicin—breast cancer	4.79e-05	0.000198	CcSEcCtD
Tamsulosin—Dyspnoea—Epirubicin—breast cancer	4.77e-05	0.000197	CcSEcCtD
Tamsulosin—Somnolence—Epirubicin—breast cancer	4.76e-05	0.000197	CcSEcCtD
Tamsulosin—Nausea—Docetaxel—breast cancer	4.71e-05	0.000195	CcSEcCtD
Tamsulosin—Feeling abnormal—Methotrexate—breast cancer	4.71e-05	0.000195	CcSEcCtD
Tamsulosin—Dyspepsia—Epirubicin—breast cancer	4.71e-05	0.000195	CcSEcCtD
Tamsulosin—Gastrointestinal pain—Methotrexate—breast cancer	4.68e-05	0.000194	CcSEcCtD
Tamsulosin—Hypotension—Doxorubicin—breast cancer	4.63e-05	0.000191	CcSEcCtD
Tamsulosin—Gastrointestinal disorder—Epirubicin—breast cancer	4.62e-05	0.000191	CcSEcCtD
Tamsulosin—Fatigue—Epirubicin—breast cancer	4.62e-05	0.000191	CcSEcCtD
Tamsulosin—Constipation—Epirubicin—breast cancer	4.58e-05	0.000189	CcSEcCtD
Tamsulosin—Pain—Epirubicin—breast cancer	4.58e-05	0.000189	CcSEcCtD
Tamsulosin—Nausea—Capecitabine—breast cancer	4.56e-05	0.000189	CcSEcCtD
Tamsulosin—Urticaria—Methotrexate—breast cancer	4.54e-05	0.000188	CcSEcCtD
Tamsulosin—Abdominal pain—Methotrexate—breast cancer	4.52e-05	0.000187	CcSEcCtD
Tamsulosin—Body temperature increased—Methotrexate—breast cancer	4.52e-05	0.000187	CcSEcCtD
Tamsulosin—Musculoskeletal discomfort—Doxorubicin—breast cancer	4.51e-05	0.000187	CcSEcCtD
Tamsulosin—Insomnia—Doxorubicin—breast cancer	4.48e-05	0.000185	CcSEcCtD
Tamsulosin—Paraesthesia—Doxorubicin—breast cancer	4.45e-05	0.000184	CcSEcCtD
Tamsulosin—Dyspnoea—Doxorubicin—breast cancer	4.42e-05	0.000183	CcSEcCtD
Tamsulosin—Feeling abnormal—Epirubicin—breast cancer	4.41e-05	0.000182	CcSEcCtD
Tamsulosin—Somnolence—Doxorubicin—breast cancer	4.4e-05	0.000182	CcSEcCtD
Tamsulosin—Gastrointestinal pain—Epirubicin—breast cancer	4.38e-05	0.000181	CcSEcCtD
Tamsulosin—Dyspepsia—Doxorubicin—breast cancer	4.36e-05	0.00018	CcSEcCtD
Tamsulosin—Gastrointestinal disorder—Doxorubicin—breast cancer	4.28e-05	0.000177	CcSEcCtD
Tamsulosin—Fatigue—Doxorubicin—breast cancer	4.27e-05	0.000177	CcSEcCtD
Tamsulosin—Urticaria—Epirubicin—breast cancer	4.25e-05	0.000176	CcSEcCtD
Tamsulosin—Pain—Doxorubicin—breast cancer	4.24e-05	0.000175	CcSEcCtD
Tamsulosin—Constipation—Doxorubicin—breast cancer	4.24e-05	0.000175	CcSEcCtD
Tamsulosin—Body temperature increased—Epirubicin—breast cancer	4.23e-05	0.000175	CcSEcCtD
Tamsulosin—Abdominal pain—Epirubicin—breast cancer	4.23e-05	0.000175	CcSEcCtD
Tamsulosin—Hypersensitivity—Methotrexate—breast cancer	4.21e-05	0.000174	CcSEcCtD
Tamsulosin—Asthenia—Methotrexate—breast cancer	4.1e-05	0.00017	CcSEcCtD
Tamsulosin—Feeling abnormal—Doxorubicin—breast cancer	4.08e-05	0.000169	CcSEcCtD
Tamsulosin—Gastrointestinal pain—Doxorubicin—breast cancer	4.05e-05	0.000168	CcSEcCtD
Tamsulosin—Pruritus—Methotrexate—breast cancer	4.05e-05	0.000167	CcSEcCtD
Tamsulosin—Hypersensitivity—Epirubicin—breast cancer	3.94e-05	0.000163	CcSEcCtD
Tamsulosin—Urticaria—Doxorubicin—breast cancer	3.94e-05	0.000163	CcSEcCtD
Tamsulosin—Body temperature increased—Doxorubicin—breast cancer	3.92e-05	0.000162	CcSEcCtD
Tamsulosin—Abdominal pain—Doxorubicin—breast cancer	3.92e-05	0.000162	CcSEcCtD
Tamsulosin—Diarrhoea—Methotrexate—breast cancer	3.91e-05	0.000162	CcSEcCtD
Tamsulosin—Asthenia—Epirubicin—breast cancer	3.84e-05	0.000159	CcSEcCtD
Tamsulosin—Pruritus—Epirubicin—breast cancer	3.79e-05	0.000157	CcSEcCtD
Tamsulosin—Dizziness—Methotrexate—breast cancer	3.78e-05	0.000156	CcSEcCtD
Tamsulosin—Diarrhoea—Epirubicin—breast cancer	3.66e-05	0.000152	CcSEcCtD
Tamsulosin—Hypersensitivity—Doxorubicin—breast cancer	3.65e-05	0.000151	CcSEcCtD
Tamsulosin—Vomiting—Methotrexate—breast cancer	3.64e-05	0.00015	CcSEcCtD
Tamsulosin—Rash—Methotrexate—breast cancer	3.61e-05	0.000149	CcSEcCtD
Tamsulosin—Dermatitis—Methotrexate—breast cancer	3.6e-05	0.000149	CcSEcCtD
Tamsulosin—Headache—Methotrexate—breast cancer	3.58e-05	0.000148	CcSEcCtD
Tamsulosin—Asthenia—Doxorubicin—breast cancer	3.55e-05	0.000147	CcSEcCtD
Tamsulosin—Dizziness—Epirubicin—breast cancer	3.54e-05	0.000146	CcSEcCtD
Tamsulosin—Pruritus—Doxorubicin—breast cancer	3.5e-05	0.000145	CcSEcCtD
Tamsulosin—Vomiting—Epirubicin—breast cancer	3.4e-05	0.000141	CcSEcCtD
Tamsulosin—Nausea—Methotrexate—breast cancer	3.4e-05	0.000141	CcSEcCtD
Tamsulosin—Diarrhoea—Doxorubicin—breast cancer	3.39e-05	0.00014	CcSEcCtD
Tamsulosin—Rash—Epirubicin—breast cancer	3.38e-05	0.00014	CcSEcCtD
Tamsulosin—Dermatitis—Epirubicin—breast cancer	3.37e-05	0.00014	CcSEcCtD
Tamsulosin—Headache—Epirubicin—breast cancer	3.35e-05	0.000139	CcSEcCtD
Tamsulosin—Dizziness—Doxorubicin—breast cancer	3.28e-05	0.000136	CcSEcCtD
Tamsulosin—Nausea—Epirubicin—breast cancer	3.18e-05	0.000132	CcSEcCtD
Tamsulosin—Vomiting—Doxorubicin—breast cancer	3.15e-05	0.00013	CcSEcCtD
Tamsulosin—Rash—Doxorubicin—breast cancer	3.12e-05	0.000129	CcSEcCtD
Tamsulosin—Dermatitis—Doxorubicin—breast cancer	3.12e-05	0.000129	CcSEcCtD
Tamsulosin—Headache—Doxorubicin—breast cancer	3.1e-05	0.000128	CcSEcCtD
Tamsulosin—Nausea—Doxorubicin—breast cancer	2.94e-05	0.000122	CcSEcCtD
Tamsulosin—CYP2D6—Metabolism—MTHFR—breast cancer	3.7e-06	4.45e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—NOS3—breast cancer	3.7e-06	4.45e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—SLC5A5—breast cancer	3.7e-06	4.45e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—KRAS—breast cancer	3.69e-06	4.45e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—EGFR—breast cancer	3.69e-06	4.44e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—PIK3CB—breast cancer	3.65e-06	4.4e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—IGF1—breast cancer	3.65e-06	4.39e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—AKT2—breast cancer	3.65e-06	4.39e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—CDKN1B—breast cancer	3.65e-06	4.39e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—EGFR—breast cancer	3.63e-06	4.37e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—PTGS2—breast cancer	3.62e-06	4.36e-05	CbGpPWpGaD
Tamsulosin—HTR1A—GPCR downstream signaling—AKT1—breast cancer	3.61e-06	4.34e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—CASP3—breast cancer	3.58e-06	4.3e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—SRC—breast cancer	3.58e-06	4.3e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—SRC—breast cancer	3.58e-06	4.3e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—IL2—breast cancer	3.57e-06	4.3e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—NQO1—breast cancer	3.57e-06	4.3e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—SLC2A1—breast cancer	3.57e-06	4.3e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—NOS3—breast cancer	3.56e-06	4.29e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—CXCL8—breast cancer	3.56e-06	4.28e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling by GPCR—IL6—breast cancer	3.55e-06	4.28e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling by GPCR—HRAS—breast cancer	3.54e-06	4.25e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—PIK3CA—breast cancer	3.52e-06	4.24e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—MDM2—breast cancer	3.51e-06	4.22e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—PIK3CD—breast cancer	3.51e-06	4.22e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—RAF1—breast cancer	3.5e-06	4.21e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—VEGFA—breast cancer	3.48e-06	4.19e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—VEGFA—breast cancer	3.48e-06	4.19e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—KRAS—breast cancer	3.48e-06	4.19e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—RELA—breast cancer	3.48e-06	4.19e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—CCND1—breast cancer	3.48e-06	4.19e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—CDKN1B—breast cancer	3.47e-06	4.18e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—JUN—breast cancer	3.47e-06	4.18e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—GPCR downstream signaling—PIK3CA—breast cancer	3.47e-06	4.18e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—SERPINE1—breast cancer	3.47e-06	4.17e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—ERBB2—breast cancer	3.46e-06	4.16e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—STAT3—breast cancer	3.45e-06	4.15e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—STAT3—breast cancer	3.45e-06	4.15e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—CTNNB1—breast cancer	3.45e-06	4.15e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—GPCR downstream signaling—AKT1—breast cancer	3.44e-06	4.14e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—KRAS—breast cancer	3.43e-06	4.13e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—CYP1B1—breast cancer	3.42e-06	4.12e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—PIK3CB—breast cancer	3.41e-06	4.11e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—MTOR—breast cancer	3.41e-06	4.11e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—CAV1—breast cancer	3.41e-06	4.11e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—CASP3—breast cancer	3.41e-06	4.1e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—IL2—breast cancer	3.4e-06	4.09e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—PIK3CA—breast cancer	3.39e-06	4.09e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling by GPCR—IL6—breast cancer	3.38e-06	4.07e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—MDM2—breast cancer	3.38e-06	4.07e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—MMP9—breast cancer	3.38e-06	4.07e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—RAF1—breast cancer	3.37e-06	4.05e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—CDKN1A—breast cancer	3.37e-06	4.05e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—PTEN—breast cancer	3.36e-06	4.04e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—HSP90AA1—breast cancer	3.36e-06	4.04e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—RELA—breast cancer	3.35e-06	4.04e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—ERBB2—breast cancer	3.33e-06	4.01e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—CCND1—breast cancer	3.31e-06	3.99e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—NOS3—breast cancer	3.31e-06	3.98e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—JUN—breast cancer	3.31e-06	3.98e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—MAPK3—breast cancer	3.29e-06	3.96e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—MAPK3—breast cancer	3.29e-06	3.96e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—MTOR—breast cancer	3.29e-06	3.96e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—PIK3CB—breast cancer	3.29e-06	3.96e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—MAPK8—breast cancer	3.29e-06	3.96e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—CTNNB1—breast cancer	3.28e-06	3.95e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—CXCL8—breast cancer	3.28e-06	3.95e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling by GPCR—AKT1—breast cancer	3.28e-06	3.95e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—NCOA1—breast cancer	3.27e-06	3.93e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—HRAS—breast cancer	3.26e-06	3.92e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—MMP9—breast cancer	3.22e-06	3.87e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—STK11—breast cancer	3.22e-06	3.87e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—CYP19A1—breast cancer	3.22e-06	3.87e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—CDKN1A—breast cancer	3.21e-06	3.86e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—CDKN1B—breast cancer	3.2e-06	3.86e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—MYC—breast cancer	3.2e-06	3.86e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—MYC—breast cancer	3.2e-06	3.86e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—PTEN—breast cancer	3.2e-06	3.85e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—PIK3CA—breast cancer	3.2e-06	3.85e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—TGFB1—breast cancer	3.2e-06	3.85e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—TGFB1—breast cancer	3.2e-06	3.85e-05	CbGpPWpGaD
Tamsulosin—DRD2—GPCR downstream signaling—AKT1—breast cancer	3.17e-06	3.81e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—CXCL8—breast cancer	3.16e-06	3.8e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—PTEN—breast cancer	3.16e-06	3.8e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—PIK3CA—breast cancer	3.15e-06	3.8e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—MDM2—breast cancer	3.14e-06	3.78e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—HRAS—breast cancer	3.14e-06	3.78e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—CASP3—breast cancer	3.14e-06	3.78e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—IL2—breast cancer	3.14e-06	3.77e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—EGFR—breast cancer	3.13e-06	3.77e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—EGFR—breast cancer	3.13e-06	3.77e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—MAPK8—breast cancer	3.13e-06	3.77e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—RAF1—breast cancer	3.13e-06	3.77e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling by GPCR—AKT1—breast cancer	3.12e-06	3.76e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—IL6—breast cancer	3.12e-06	3.75e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—RELA—breast cancer	3.12e-06	3.75e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—SRC—breast cancer	3.12e-06	3.75e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PIK3CG—breast cancer	3.11e-06	3.74e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—ERBB2—breast cancer	3.1e-06	3.73e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—TP53—breast cancer	3.09e-06	3.72e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—CDKN1B—breast cancer	3.09e-06	3.71e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—CCND1—breast cancer	3.06e-06	3.68e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—MTOR—breast cancer	3.06e-06	3.68e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—PIK3CB—breast cancer	3.06e-06	3.68e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—GPCR downstream signaling—AKT1—breast cancer	3.05e-06	3.67e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—JUN—breast cancer	3.05e-06	3.67e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—VEGFA—breast cancer	3.03e-06	3.65e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—CTNNB1—breast cancer	3.03e-06	3.64e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—CASP3—breast cancer	3.03e-06	3.64e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—IL2—breast cancer	3.02e-06	3.64e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—IL6—breast cancer	3.01e-06	3.62e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—STAT3—breast cancer	3e-06	3.62e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—COMT—breast cancer	2.99e-06	3.6e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—GSTP1—breast cancer	2.98e-06	3.58e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—SRC—breast cancer	2.97e-06	3.57e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—MMP9—breast cancer	2.97e-06	3.57e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—KRAS—breast cancer	2.96e-06	3.56e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—KRAS—breast cancer	2.96e-06	3.56e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—HRAS—breast cancer	2.96e-06	3.56e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—CDKN1A—breast cancer	2.96e-06	3.56e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—PTEN—breast cancer	2.95e-06	3.55e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—CCND1—breast cancer	2.94e-06	3.54e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—JUN—breast cancer	2.94e-06	3.54e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—HMOX1—breast cancer	2.94e-06	3.53e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CXCL8—breast cancer	2.94e-06	3.53e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—ITPR1—breast cancer	2.93e-06	3.53e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—HRAS—breast cancer	2.92e-06	3.51e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	2.92e-06	3.51e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—VEGFA—breast cancer	2.89e-06	3.48e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—MAPK8—breast cancer	2.89e-06	3.47e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—AKT1—breast cancer	2.88e-06	3.46e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—MAPK3—breast cancer	2.87e-06	3.46e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CDKN1B—breast cancer	2.87e-06	3.45e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—STAT3—breast cancer	2.86e-06	3.44e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—MMP9—breast cancer	2.86e-06	3.44e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	2.85e-06	3.43e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—PTEN—breast cancer	2.84e-06	3.42e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	2.84e-06	3.41e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—IL6—breast cancer	2.83e-06	3.41e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—ABCB1—breast cancer	2.82e-06	3.39e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CASP3—breast cancer	2.81e-06	3.38e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—IL2—breast cancer	2.81e-06	3.38e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—IL6—breast cancer	2.79e-06	3.36e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—MYC—breast cancer	2.79e-06	3.36e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—TGFB1—breast cancer	2.79e-06	3.35e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—MAPK8—breast cancer	2.78e-06	3.35e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—AKT1—breast cancer	2.77e-06	3.34e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—TYMS—breast cancer	2.77e-06	3.33e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—NCOR1—breast cancer	2.74e-06	3.29e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.74e-06	3.29e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—GSTM1—breast cancer	2.74e-06	3.29e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CCND1—breast cancer	2.74e-06	3.29e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—SRC—breast cancer	2.74e-06	3.29e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—MAPK3—breast cancer	2.73e-06	3.29e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PIK3CD—breast cancer	2.73e-06	3.29e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—EGFR—breast cancer	2.73e-06	3.29e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—JUN—breast cancer	2.73e-06	3.29e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—PIK3CA—breast cancer	2.72e-06	3.27e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—PIK3CA—breast cancer	2.72e-06	3.27e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	2.71e-06	3.26e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—ALB—breast cancer	2.7e-06	3.25e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—VEGFA—breast cancer	2.66e-06	3.21e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—MYC—breast cancer	2.66e-06	3.2e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—MMP9—breast cancer	2.66e-06	3.2e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—TGFB1—breast cancer	2.65e-06	3.19e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	2.65e-06	3.19e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—PTEN—breast cancer	2.64e-06	3.18e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—STAT3—breast cancer	2.64e-06	3.18e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—SRC—breast cancer	2.64e-06	3.17e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—TP53—breast cancer	2.63e-06	3.17e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—TP53—breast cancer	2.63e-06	3.17e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—GPX1—breast cancer	2.62e-06	3.15e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—AKT1—breast cancer	2.61e-06	3.14e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—EGFR—breast cancer	2.6e-06	3.13e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—CYP1A1—breast cancer	2.59e-06	3.12e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—MAPK8—breast cancer	2.58e-06	3.11e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—NOS3—breast cancer	2.58e-06	3.11e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—KRAS—breast cancer	2.58e-06	3.11e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—AKT1—breast cancer	2.58e-06	3.1e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—ERCC2—breast cancer	2.57e-06	3.1e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—VEGFA—breast cancer	2.57e-06	3.09e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—STAT3—breast cancer	2.54e-06	3.06e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—MAPK3—breast cancer	2.52e-06	3.03e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—HRAS—breast cancer	2.52e-06	3.03e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—HRAS—breast cancer	2.52e-06	3.03e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—KRAS—breast cancer	2.46e-06	2.96e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—MYC—breast cancer	2.45e-06	2.95e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—SRC—breast cancer	2.45e-06	2.95e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—TGFB1—breast cancer	2.45e-06	2.94e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—MAPK3—breast cancer	2.43e-06	2.92e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—MTHFR—breast cancer	2.42e-06	2.91e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—IL6—breast cancer	2.41e-06	2.9e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—IL6—breast cancer	2.41e-06	2.9e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—EGFR—breast cancer	2.4e-06	2.89e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—VEGFA—breast cancer	2.39e-06	2.87e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PIK3CB—breast cancer	2.38e-06	2.87e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—PIK3CA—breast cancer	2.37e-06	2.85e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—MYC—breast cancer	2.36e-06	2.84e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—STAT3—breast cancer	2.36e-06	2.84e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PTGS2—breast cancer	2.36e-06	2.84e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—TGFB1—breast cancer	2.36e-06	2.84e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—EGFR—breast cancer	2.31e-06	2.78e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—TP53—breast cancer	2.29e-06	2.76e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—KRAS—breast cancer	2.27e-06	2.73e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	2.26e-06	2.72e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—MAPK3—breast cancer	2.26e-06	2.72e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—CAV1—breast cancer	2.23e-06	2.68e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—PIK3CA—breast cancer	2.23e-06	2.68e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—AKT1—breast cancer	2.22e-06	2.67e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—AKT1—breast cancer	2.22e-06	2.67e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—MYC—breast cancer	2.19e-06	2.64e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—HRAS—breast cancer	2.19e-06	2.64e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—TGFB1—breast cancer	2.19e-06	2.63e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—TP53—breast cancer	2.18e-06	2.63e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—KRAS—breast cancer	2.18e-06	2.63e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—EGFR—breast cancer	2.15e-06	2.58e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—IL6—breast cancer	2.1e-06	2.53e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—HRAS—breast cancer	2.09e-06	2.51e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—PIK3CA—breast cancer	2.08e-06	2.5e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PTEN—breast cancer	2.06e-06	2.48e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PIK3CG—breast cancer	2.03e-06	2.45e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—KRAS—breast cancer	2.03e-06	2.44e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—TP53—breast cancer	2.01e-06	2.42e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	2e-06	2.41e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—IL6—breast cancer	2e-06	2.41e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—TP53—breast cancer	1.94e-06	2.33e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—AKT1—breast cancer	1.94e-06	2.33e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—HRAS—breast cancer	1.93e-06	2.32e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	1.86e-06	2.24e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—HRAS—breast cancer	1.85e-06	2.23e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—AKT1—breast cancer	1.84e-06	2.22e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—IL6—breast cancer	1.84e-06	2.22e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—AKT1—breast cancer	1.82e-06	2.19e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—TP53—breast cancer	1.8e-06	2.17e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PIK3CD—breast cancer	1.79e-06	2.15e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—IL6—breast cancer	1.78e-06	2.14e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—ALB—breast cancer	1.76e-06	2.12e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—HRAS—breast cancer	1.72e-06	2.07e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—AKT1—breast cancer	1.7e-06	2.05e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—NOS3—breast cancer	1.69e-06	2.03e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—IL6—breast cancer	1.65e-06	1.99e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—AKT1—breast cancer	1.64e-06	1.97e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PIK3CB—breast cancer	1.56e-06	1.87e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PTGS2—breast cancer	1.54e-06	1.86e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—AKT1—breast cancer	1.52e-06	1.83e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PIK3CA—breast cancer	1.45e-06	1.75e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PTEN—breast cancer	1.35e-06	1.62e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—AKT1—breast cancer	1.19e-06	1.43e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PIK3CA—breast cancer	9.49e-07	1.14e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—AKT1—breast cancer	7.75e-07	9.33e-06	CbGpPWpGaD
